Physician profile
Shadi Halabi
NPI 1306285051
$30,860.15
in general payments reported to CMS, 2019-2025
42 companies · $970 in 2025
The $970 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,113 · 2020: $2,379 · 2021: $1,535 · 2022: $2,804 · 2023: $8,166 · 2024: $7,893 · 2025: $970.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,905 · Honoraria: $5,635 · Food and Beverage: $2,858 · Travel and Lodging: $554 · Entertainment: $76.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,905.00 |
| Honoraria | $5,635.00 |
| Food and Beverage | $2,857.90 |
| Travel and Lodging | $554.46 |
| Entertainment | $76.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $13,263.18 | 2019-2025 | (6554) Periph Vasc Undiv, (6554) Peripheral Vascular Undivided, (9520) Igt Devices Undivided |
| Abbott Laboratories | $6,241.38 | 2019-2023 | Supera, Optis, Jeti |
| Boston Scientific Corporation | $3,506.42 | 2019-2025 | Watchman Flx |
| Cook Incorporated | $1,057.20 | 2023 | Zilver Ptx |
| Inari Medical, INC. | $806.13 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $650.91 | 2020-2025 | Lifevest |
| Cardiovascular Systems INC. | $531.73 | 2019-2021 | |
| Medtronic, INC. | $468.51 | 2021-2025 | Hawkone, Corevalve Evolut R, Concertotm |
| Janssen Pharmaceuticals, INC | $429.86 | 2019-2023 | Xarelto |
| Terumo Medical Corporation | $423.65 | 2019-2020 | |
| Cook Medical LLC | $340.23 | 2019-2023 | Rosen |
| Medtronic Vascular, INC. | $337.03 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $291.41 | 2020-2025 | |
| W. L. Gore & Associates, INC. | $291.06 | 2024 | Product In Development, Gore Viabahn Vbx Balloon Expandable Endo |
| Avinger INC. | $284.18 | 2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $270.99 | 2022-2023 | Indigo System |
| Amgen INC. | $186.56 | 2019-2025 | Repatha, Repatha |
| Livanova USA, INC. | $131.29 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $129.84 | 2020-2022 | |
| Atricure, INC. | $126.80 | 2023-2024 | |
| Inspire Medical Systems, INC. | $125.07 | 2023-2024 | Inspire |
| Intuitive Surgical, INC. | $112.24 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $92.95 | 2019-2021 | |
| Opsens INC. | $92.84 | 2022-2023 | Optowire |
| Cardiva Medical, INC. | $89.09 | 2024-2025 | Optowire |
| Edwards Lifesciences Corporation | $83.46 | 2025 | Sapien 3 Ultra Resilia |
| Bard Peripheral Vascular, INC. | $49.97 | 2022 | |
| Tactile Systems Technology INC | $48.33 | 2024 | Flexitouch Plus, Entre Plus |
| Scpharmaceuticals INC. | $47.10 | 2024 | |
| Merck Sharp & Dohme LLC | $43.88 | 2022-2023 | Verquvo |
| Pfizer INC. | $40.71 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $38.05 | 2024 | Arcalyst |
| Chiesi USA, INC. | $37.17 | 2022-2025 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.70 | 2022-2023 | Jardiance |
| Angiodynamics, INC. | $28.40 | 2022 | |
| Novo Nordisk INC | $27.74 | 2025 | Wegovy |
| Argon Medical Devices, INC. | $20.39 | 2025 | Clot Management |
| Kiniksa Pharmaceuticals, Ltd. | $16.82 | 2023 | Arcalyst |
| Cvrx, INC. | $16.68 | 2024 | Barostim Neo System |
| Cordis US Corp. | $16.50 | 2024 | Mynx Venous Vcd |
| Asahi Intecc USA, INC. | $15.57 | 2022 | |
| Glaxosmithkline, LLC. | $14.13 | 2024 | Pediarix, Bexsero, Rotarix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shadi Halabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.